Imfinzi (durvalumab) - AstraZeneca
Yervoy (ipilimumab) - BMS
pemetrexed - Generic mfg.
Opdivo (nivolumab) - BMS
carboplatin - Generic mfg.
ONCOS-102 - Circio Holding
Recentin (cediranib) - AstraZeneca
Avastin (bevacizumab) - Roche
Keytruda (pembrolizumab) - Merck (MSD)
cisplatin - Generic mfg.
http://www.ncbi.nlm.nih.gov/pubmed/39941870
 
Andrea Messori; Eugenia Piragine; Sabrina Trippoli; Sara Veneziano; Vincenzo Calderone
 
Feb 13, 2025
 
Next